Orient Bio., Inc.
1Patents
1Active
1Granted
42Portfolio score
Filing activity: Nov 23, 2007 → Nov 23, 2007 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7626076B2 | Transgenic mouse whose genome comprises a homozygous disruption of its α1G gene, a method of preparing the same and use thereof | Human Necessities | 22 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.